The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Targeting DNA Repair Drugs Market Research Report 2025

Global Targeting DNA Repair Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1769170

No of Pages : 97

Ask Your Query

Synopsis
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.

Global Targeting DNA Repair Drugs market is projected to reach US$ 1639.5 million in 2029, increasing from US$ 598 million in 2022, with the CAGR of 15.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Targeting DNA Repair Drugs market research.

In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Targeting DNA Repair Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Onxeo
  • FoRx Therapeutics
  • Artios Pharma Limited
  • Merck KGaA
  • Breakpoint Therapeutics
  • Luciole Pharmaceuticals
  • AstraZeneca
  • AbbVie
  • Johnson & Johnson
  • Pfizer
  • ClovisOncology
  • GlaxoSmithKline

Segment by Type

  • Olaparib
  • Rucaparib
  • Niraparib
  • Talazoparib
  • Others

Segment by Application

  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer
  • Breast Cancer
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Targeting DNA Repair Drugs report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Targeting DNA Repair Drugs Market Overview
1.1 Product Overview and Scope of Targeting DNA Repair Drugs
1.2 Targeting DNA Repair Drugs Segment by Type
1.2.1 Global Targeting DNA Repair Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Olaparib
1.2.3 Rucaparib
1.2.4 Niraparib
1.2.5 Talazoparib
1.2.6 Others
1.3 Targeting DNA Repair Drugs Segment by Application
1.3.1 Global Targeting DNA Repair Drugs Market Value by Application: (2023-2029)
1.3.2 Ovarian Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Peritoneal Cancer
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Targeting DNA Repair Drugs Market Size Estimates and Forecasts
1.4.1 Global Targeting DNA Repair Drugs Revenue 2018-2029
1.4.2 Global Targeting DNA Repair Drugs Sales 2018-2029
1.4.3 Global Targeting DNA Repair Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Targeting DNA Repair Drugs Market Competition by Manufacturers
2.1 Global Targeting DNA Repair Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Targeting DNA Repair Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Targeting DNA Repair Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Targeting DNA Repair Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Targeting DNA Repair Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Targeting DNA Repair Drugs, Product Type & Application
2.7 Targeting DNA Repair Drugs Market Competitive Situation and Trends
2.7.1 Targeting DNA Repair Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Targeting DNA Repair Drugs Players Market Share by Revenue
2.7.3 Global Targeting DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Targeting DNA Repair Drugs Retrospective Market Scenario by Region
3.1 Global Targeting DNA Repair Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Targeting DNA Repair Drugs Global Targeting DNA Repair Drugs Sales by Region: 2018-2029
3.2.1 Global Targeting DNA Repair Drugs Sales by Region: 2018-2023
3.2.2 Global Targeting DNA Repair Drugs Sales by Region: 2024-2029
3.3 Global Targeting DNA Repair Drugs Global Targeting DNA Repair Drugs Revenue by Region: 2018-2029
3.3.1 Global Targeting DNA Repair Drugs Revenue by Region: 2018-2023
3.3.2 Global Targeting DNA Repair Drugs Revenue by Region: 2024-2029
3.4 North America Targeting DNA Repair Drugs Market Facts & Figures by Country
3.4.1 North America Targeting DNA Repair Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Targeting DNA Repair Drugs Sales by Country (2018-2029)
3.4.3 North America Targeting DNA Repair Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Targeting DNA Repair Drugs Market Facts & Figures by Country
3.5.1 Europe Targeting DNA Repair Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Targeting DNA Repair Drugs Sales by Country (2018-2029)
3.5.3 Europe Targeting DNA Repair Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Targeting DNA Repair Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Targeting DNA Repair Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Targeting DNA Repair Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Targeting DNA Repair Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Targeting DNA Repair Drugs Market Facts & Figures by Country
3.7.1 Latin America Targeting DNA Repair Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Targeting DNA Repair Drugs Sales by Country (2018-2029)
3.7.3 Latin America Targeting DNA Repair Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Targeting DNA Repair Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Targeting DNA Repair Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Targeting DNA Repair Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Targeting DNA Repair Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Targeting DNA Repair Drugs Sales by Type (2018-2029)
4.1.1 Global Targeting DNA Repair Drugs Sales by Type (2018-2023)
4.1.2 Global Targeting DNA Repair Drugs Sales by Type (2024-2029)
4.1.3 Global Targeting DNA Repair Drugs Sales Market Share by Type (2018-2029)
4.2 Global Targeting DNA Repair Drugs Revenue by Type (2018-2029)
4.2.1 Global Targeting DNA Repair Drugs Revenue by Type (2018-2023)
4.2.2 Global Targeting DNA Repair Drugs Revenue by Type (2024-2029)
4.2.3 Global Targeting DNA Repair Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Targeting DNA Repair Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Targeting DNA Repair Drugs Sales by Application (2018-2029)
5.1.1 Global Targeting DNA Repair Drugs Sales by Application (2018-2023)
5.1.2 Global Targeting DNA Repair Drugs Sales by Application (2024-2029)
5.1.3 Global Targeting DNA Repair Drugs Sales Market Share by Application (2018-2029)
5.2 Global Targeting DNA Repair Drugs Revenue by Application (2018-2029)
5.2.1 Global Targeting DNA Repair Drugs Revenue by Application (2018-2023)
5.2.2 Global Targeting DNA Repair Drugs Revenue by Application (2024-2029)
5.2.3 Global Targeting DNA Repair Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Targeting DNA Repair Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Onxeo
6.1.1 Onxeo Corporation Information
6.1.2 Onxeo Description and Business Overview
6.1.3 Onxeo Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Onxeo Targeting DNA Repair Drugs Product Portfolio
6.1.5 Onxeo Recent Developments/Updates
6.2 FoRx Therapeutics
6.2.1 FoRx Therapeutics Corporation Information
6.2.2 FoRx Therapeutics Description and Business Overview
6.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 FoRx Therapeutics Targeting DNA Repair Drugs Product Portfolio
6.2.5 FoRx Therapeutics Recent Developments/Updates
6.3 Artios Pharma Limited
6.3.1 Artios Pharma Limited Corporation Information
6.3.2 Artios Pharma Limited Description and Business Overview
6.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Artios Pharma Limited Targeting DNA Repair Drugs Product Portfolio
6.3.5 Artios Pharma Limited Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Corporation Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck KGaA Targeting DNA Repair Drugs Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 Breakpoint Therapeutics
6.5.1 Breakpoint Therapeutics Corporation Information
6.5.2 Breakpoint Therapeutics Description and Business Overview
6.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Breakpoint Therapeutics Targeting DNA Repair Drugs Product Portfolio
6.5.5 Breakpoint Therapeutics Recent Developments/Updates
6.6 Luciole Pharmaceuticals
6.6.1 Luciole Pharmaceuticals Corporation Information
6.6.2 Luciole Pharmaceuticals Description and Business Overview
6.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product Portfolio
6.6.5 Luciole Pharmaceuticals Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Targeting DNA Repair Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AbbVie Targeting DNA Repair Drugs Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Johnson & Johnson Targeting DNA Repair Drugs Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfizer Targeting DNA Repair Drugs Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 ClovisOncology
6.11.1 ClovisOncology Corporation Information
6.11.2 ClovisOncology Targeting DNA Repair Drugs Description and Business Overview
6.11.3 ClovisOncology Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ClovisOncology Targeting DNA Repair Drugs Product Portfolio
6.11.5 ClovisOncology Recent Developments/Updates
6.12 GlaxoSmithKline
6.12.1 GlaxoSmithKline Corporation Information
6.12.2 GlaxoSmithKline Targeting DNA Repair Drugs Description and Business Overview
6.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 GlaxoSmithKline Targeting DNA Repair Drugs Product Portfolio
6.12.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Targeting DNA Repair Drugs Industry Chain Analysis
7.2 Targeting DNA Repair Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Targeting DNA Repair Drugs Production Mode & Process
7.4 Targeting DNA Repair Drugs Sales and Marketing
7.4.1 Targeting DNA Repair Drugs Sales Channels
7.4.2 Targeting DNA Repair Drugs Distributors
7.5 Targeting DNA Repair Drugs Customers
8 Targeting DNA Repair Drugs Market Dynamics
8.1 Targeting DNA Repair Drugs Industry Trends
8.2 Targeting DNA Repair Drugs Market Drivers
8.3 Targeting DNA Repair Drugs Market Challenges
8.4 Targeting DNA Repair Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock